{"database": "openregs", "table": "documents", "rows": [["FDA-2005-N-0345-0001", "FDA", "FDA-2005-N-0345", "Distribution of Blood Derivatives by Registered Blood Establishments that Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures; Proposed Rule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2006-02-02T05:00:00Z", 2006, 2, "2006-01-31T05:00:00Z", "2006-05-03T03:59:59Z", "2025-10-16T22:13:32Z", "E6-1225", 0, 0, "0900006480449864"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2005-N-0345-0001"], "units": {}, "query_ms": 0.5085261072963476, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}